<?xml version="1.0" encoding="UTF-8"?>
<ref id="bjh15394-bib-0042">
 <mixed-citation publication-type="journal" id="bjh15394-cit-0042">
  <string-name>
   <surname>Richardson</surname>, 
   <given-names>P.G.</given-names>
  </string-name>, 
  <string-name>
   <surname>Baz</surname>, 
   <given-names>R.</given-names>
  </string-name>, 
  <string-name>
   <surname>Wang</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Jakubowiak</surname>, 
   <given-names>A.J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Laubach</surname>, 
   <given-names>J.P.</given-names>
  </string-name>, 
  <string-name>
   <surname>Harvey</surname>, 
   <given-names>R.D.</given-names>
  </string-name>, 
  <string-name>
   <surname>Talpaz</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Berg</surname>, 
   <given-names>D.</given-names>
  </string-name>, 
  <string-name>
   <surname>Liu</surname>, 
   <given-names>G.</given-names>
  </string-name>, 
  <string-name>
   <surname>Yu</surname>, 
   <given-names>J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Gupta</surname>, 
   <given-names>N.</given-names>
  </string-name>, 
  <string-name>
   <surname>Di Bacco</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Hui</surname>, 
   <given-names>A.M.</given-names>
  </string-name> &amp; 
  <string-name>
   <surname>Lonial</surname>, 
   <given-names>S.</given-names>
  </string-name> (
  <year>2014</year>) 
  <article-title>Phase 1 study of twice‐weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients</article-title>. 
  <source xml:lang="en">Blood</source>, 
  <volume>124</volume>, 
  <fpage>1038</fpage>–
  <lpage>1046</lpage>.
  <pub-id pub-id-type="pmid">24920586</pub-id>
 </mixed-citation>
</ref>
